Elicio Therapeutics Inc. (ELTX) — Free Cash Flow Generation Index

Latest as of June 2022: 0.91x

Elicio Therapeutics Inc. (ELTX) has a Free Cash Flow Generation Index of 0.91x as of June 2022. Free cash flow of $5.58 Million represents 1% of operating cash flow ($6.14 Million). Read Elicio Therapeutics Inc. (ELTX) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

$5.58 Million
USD

Operating Cash Flow

$6.14 Million
USD

Capital Expenditures

$559.00K
USD

Elicio Therapeutics Inc. Free Cash Flow Generation Index (2012–2013)

Historical FCF Generation Index trend for Elicio Therapeutics Inc. across 2 annual periods. Explore ELTX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Elicio Therapeutics Inc. (2012–2013)

Year-by-year Free Cash Flow Generation Index for Elicio Therapeutics Inc.. For the full company profile including market capitalisation, see Elicio Therapeutics Inc. (ELTX) market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2013 0.99x $1.87 Million $1.89 Million $17.57K ▲ +3.7%
2012 0.96x $1.02 Million $1.07 Million $47.73K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).